Viking Therapeutics stock trades at 24.00 euros Tuesday

Company: Viking Therapeutics
ISIN: US92686J1060
Ticker: VKTX
Trading venue: Lang &amp; Schwarz
Quote: 24.00 euros
Quote time: 14:05 CET, Tuesday, November 3, 2026

Published on 11/03/2026 at 14:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Viking Therapeutics stock traded on Lang & Schwarz during Tuesday afternoon trading. Its obesity pipeline remains the main investor focus.

Viking Therapeutics stock update

Viking Therapeutics stock traded on Lang & Schwarz during Tuesday afternoon trading.
The company remains focused on advancing its VK2735 obesity programs.

VKTX, US92686J1060, Illustration mit AI erstellt.

Viking Therapeutics stock traded at 24.00 euros on Lang & Schwarz at 14:05 CET on Tuesday, November 3, 2026. The quote gives investors a current reference point for the U.S. biotechnology company during European afternoon trading.

Pipeline remains the key focus

Viking Therapeutics continues to center its development strategy on VK2735, an obesity treatment candidate being studied in oral and injectable programs. The company’s clinical progress and upcoming trial milestones remain the main factors shaping the investment case.

Investors can follow the real-time quote of Viking Therapeutics stock for the latest Lang & Schwarz indication.